Skip to content
HowShorted

Teladoc Health, Inc. short interest in 2022

In 2022, Teladoc Health, Inc.'s disclosed short interest ran from 13.45% of shares outstanding on 14 Jan 2022 to 17.61% on 30 Dec 2022, a change of +4.16 percentage points. The year's high was 23.70% on 13 May 2022 and its low 13.45% on 14 Jan 2022, averaging 18.57% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.66 days on 14 Apr 2022. Full history: Teladoc Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Teladoc Health, Inc. in 2022

2022 in figures

Start of year
13.45% (14 Jan 2022)
End of year
17.61% (30 Dec 2022)
Change
+4.16 pp
High
23.70% (13 May 2022)
Low
13.45% (14 Jan 2022)
Average
18.57%
Highest days to cover
8.66 (14 Apr 2022)
SEC filings marked
9

Every report in 2022

Teladoc Health, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202213.45%5.17results (8-K)
31 Jan 202213.51%4.65
15 Feb 202214.72%6.16
28 Feb 202214.92%2.98results (8-K), 10-K filed
15 Mar 202216.06%5.49
31 Mar 202215.56%6.59
14 Apr 202215.93%8.66
29 Apr 202217.25%1.82results (8-K)
13 May 202223.70%2.6510-Q filed
31 May 202222.86%6.34
15 Jun 202222.74%7.02
30 Jun 202222.44%6.52
15 Jul 202220.66%6.83
29 Jul 202218.79%4.15results (8-K)
15 Aug 202219.60%6.4110-Q filed
31 Aug 202220.75%7.90
15 Sep 202219.87%7.73
30 Sep 202220.66%6.79
14 Oct 202220.47%7.52
31 Oct 202219.43%5.47results (8-K)
15 Nov 202218.64%6.3010-Q filed
30 Nov 202218.11%6.58
15 Dec 202217.87%7.79
30 Dec 202217.61%6.68

See also: Teladoc Health, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.